Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
Details for Australian Patent Application No. 2007260822 (hide)
International Classifications
Event Publications
8 January 2009 PCT application entered the National Phase
PCT publication WO2007/150075 Priority application(s): WO2007/150075
14 April 2011 Amendment Made
The nature of the amendment is: Amend the name of the inventor to read Stark, Paul; Liversidge, Gary; Devane, John; Jenkins, Scott; Fanning, Niall; SinghRekhi, Gurvinder; Cooper, Eugene R.; Ryde, Tuula; Pruitt, John and Kline, Laura
21 June 2012 Assignment before Grant
Elan Pharma International Limited The application has been assigned to Alkermes Pharma Ireland Limited
5 July 2012 Application Accepted
Published as AU-B-2007260822
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007260821-Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser